• Most Popular
  • Most Shared

Genmab says gets $5.6 mln milestone payment from Glaxo

Fri Oct 10, 2008 10:27am EDT

Stocks

   

COPENHAGEN, Oct 10 (Reuters) - Danish biotech firm Genmab (GEN.CO) said on Friday it received a $5.6 million milestone payment from partner GlaxoSmithKline (GSK.L) for treating the first patient in a Phase I study for its drug HuMax-CD20.

The drug, also known as ofatumumab, is an antibody being developed for the treatment of relapsed/refractory follicular non-Hodgkin's lymphoma and chronic lymphocytic leukemia, among other ailments. (Reporting by Gelu Sulugiuc; Editing by Quentin Bryar)



More from Reuters

Photo

Fox, Time Warner Cable ink temp deal to avoid blackout

NEW YORK (Reuters) - Time Warner Cable and News Corp's Fox Networks agreed to a brief extension of their current carriage contract on Thursday to avoid a blackout that would have prevented 13 million U.S. homes from seeing TV shows like "The Simpsons" and college and NFL football games.

» More Top News
A customer is served at a counter inside a foreign exchange store displaying a poster of various banknotes including the Chinese yuan or renminbi (RMB) in Hong Kong November 20, 2009. REUTERS/Bobby Yip
OUTLOOK 2010:

Be careful what you wish for

Pressure on China to loosen its grip on the yuan will continue but the U.S. should tread carefully. Here are five world market issues to watch.  Full Article 

Global Markets
Aurora, a 20-year-old Beluga whale, swims with her newborn calf after giving birth at the Vancouver Aquarium in Vancouver, British Columbia June 7, 2009. REUTERS/Andy Clark

365 days for the doomed

From polar bears to emperor penguins, endangered species will get top online billing in 2010 during the Year of Biodiversity.  Full Article 

Green Business